Full Description
Numerous new and important findings relating to the reconstruction of disturbed circulatory conditions in the coronary area are reported in this book. Fundamental aspects of therapeutic and prophylactic possibilities are covered in detail. Recommendations are then made to practitioners and clinicians for their everyday work. Critical standards for the indications and risks of the recommended procedures are given. Particular emphasis is laid on the possibilities for revascularization by means of dissolution of blood thrombi. The book aims to present top-level guidance to the pros and cons of reconstructive measures in coronary disorders.
Contents
Session I. Pathophysiology of Salvage of Ischemic Myocardium by Reperfusion.- Acute Regional Ischemia.- The Role of Free Radical Scavengers in Reperfusion.- Calcium and the Stunned Myocardium.- The No-Reflow Phenomenon.- Microcirculation in Myocardial Ischemia and Reperfusion.- Reperfusion Injury.- Discussion: Session I — Pathophysiology of Salvage of Ischemic Myocardium by Reperfusion.- Summary of Session I.- Session II. Thrombolysis in Acute Myocardial Infarction.- Thrombolysis in Acute Myocardial Infarction.- Streptokinase in Acute Myocardial Infarction — Benefits and Risks.- Results from ISAM and GISSI.- Prehospital Thrombolysis in Acute Myocardial Infarction: The Jerusalem Experience.- Extracorporal Plasma Therapy in the Treatment of Severe Hyper-?-lipoproteinemia: The HELP System.- Very Early Urokinase Treatment in Acute Myocardial Infarction.- Prourokinase in Acute Myocardial Infarction: Is It Effective?.- Recombinant Tissue-Type Plasminogen Activator in the Treatment of Myocardial Infarction.- Thrombolytic Agents in Early Myocardial Infarction—An Overview in 1987.- Is There a Role for Thrombolysis in Non-Q-Wave Myocardial Infarction and Unstable Angina Pectoris?.- Anticoagulants After Thrombolysis.- Drug Therapy in Coronary Heart Disease, Especially in the Management of Chronic Myocardial Ischemia.- Discussion: Session II — Thrombolysis in Acute Myocardial Infarction.- Session III. Percutaneous Transluminal Coronary Angioplasty.- Recommendations of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on PTCA.- The Changing Role of PTCA in Patients with Acute Myocardial Infarction.- Thrombolytic Therapy and PTCA.- Percutaneous Transluminal Coronary Angioplasty in Unstable Angina.- Drug Treatment after PTCA.-Discussion: Session III — Percutaneous Transluminal Coronary Angioplasty.- Summary of Session III.- Session IV. Coronary Bypass Surgery.- Coronary Artery Bypass Surgery — State of the Art.- Coronary Bypass Surgery After Thrombolysis and Balloon Dilatation.- Discussion: Session IV — Coronary Bypass Surgery.- Session V. Rehabilitative Care After Myocardial Revascularization.- Long-Term Care and Surveillance of the Patient Following Coronary Angioplasty or Coronary Bypass Surgery.- The Role of Exercise Testing in Assessment of Myocardial Revascularisation.- Physical Exercise in Comprehensive Care.- Cost-Effectiveness of Noninvasive Surveillance.- Rehabilitative Care After Myocardial Revascularization.- Return to Work After Coronary Artery Bypass Surgery.- Rehabilitation Systems in Different Areas of the World.- Discussion: Session V — Rehabilitative Care After Myocardial Revascularization.
